Endovia Health Sciences (EDVA) Depreciation & Amortization (CF) (2019 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,321.00 |
| Dec 31, 2025 | -101,769.00 |
| Sep 30, 2025 | 106,411.00 |
| Jun 30, 2025 | 2,321.00 |
| Mar 31, 2025 | 2,321.00 |
| Dec 31, 2024 | -3,720.00 |
| Sep 30, 2024 | 135,059.00 |
| Jun 30, 2024 | 135,032.00 |
| Mar 31, 2024 | 135,231.00 |
| Dec 31, 2023 | 142,029.00 |
| Sep 30, 2023 | 136,258.00 |
| Jun 30, 2023 | 137,072.00 |
| Mar 31, 2023 | 130,618.00 |
| Dec 31, 2022 | 629,120.00 |
| Sep 30, 2022 | 50,135.00 |
| Jun 30, 2022 | 50,877.00 |
| Mar 31, 2022 | 205,888.00 |
| Dec 31, 2021 | -8,280.00 |
| Sep 30, 2021 | 39,799.00 |
| Jun 30, 2021 | 3,542.00 |